U.S. Healthcare Services Stock News

Fidelity National Information Services stock: why recent performance has investors watching closely Fidelity National Information Services (FIS) has drawn attention after a period of weaker share performance, with the stock down over the past month, past 3 months, year to date, and past year. At a last close of US$42.69 and a market cap of about US$22.5b, the company sits against a backdrop of annual revenue of US$11.44b and net income of US$2.67b. See our latest analysis for Fidelity...

If you are wondering whether NetApp's current share price lines up with its underlying worth, this article walks through what the numbers are saying about value. The stock last closed at US$118.97, with returns of 0.3% over 7 days, 11.4% over 30 days, 11.7% year to date, 21.8% over 1 year, 91.1% over 3 years and 68.3% over 5 years. These figures give useful context before looking at valuation. Recent coverage has focused on NetApp's role in data storage and cloud infrastructure, including...

LightPath Technologies reported past third-quarter 2026 results showing sales of US$19.15 million versus US$9.17 million a year earlier, while quarterly net loss widened to US$4.11 million from US$3.58 million. Over the first nine months of the fiscal year, sales more than doubled to US$50.56 million as losses also increased, highlighting the tension between rapid top-line expansion and the cost of building out its optics and infrared solutions business. With revenue more than doubling year...

In recent months, Baron Capital added Rubrik as a new holding in its Baron Opportunity Fund, while Rubrik and MEDITECH announced a collaboration to embed Rubrik Security Cloud cyber resilience into MEDITECH’s self-hosted cloud and on-premises healthcare solutions. This combination of institutional interest and deeper penetration into healthcare data protection highlights how Rubrik’s cyber resilience platform is being validated across both capital markets and mission-critical clinical...

ACV Auctions (ACVA) is in focus after the company expanded its ACV MAX inventory intelligence suite, bringing together inspection data, guarantees, and real-time market insights into a single platform for auto dealers. See our latest analysis for ACV Auctions. Recent ACV MAX updates and upcoming conference appearances sit against a mixed trading picture, with a 16.86% 30 day share price return contrasting with a 28.11% year to date share price decline and a 63.50% drop in 1 year total...

Earlier in May 2026, International Seaways, Inc. reported first-quarter results showing revenue of US$325.48 million and net income of US$286.14 million, declared a combined regular and supplemental dividend of US$4.55 per share payable on June 26, 2026, and filed for a US$200 million at-the-market follow-on equity offering. Alongside these results, the company’s leadership continued pre-arranged share sales and completed its existing buyback program, highlighting an active approach to...

L3Harris Technologies (LHX) is drawing fresh attention after the company moved to expand production of its fiber optic tether systems, which support secure communications for military drones and underwater platforms in contested electronic environments. See our latest analysis for L3Harris Technologies. L3Harris’s latest production expansion comes after a period where the share price has eased, with a 30-day share price return down 11.31% and a 90-day share price return down 13.81%, even as...

Dorman Products (DORM) is back on investors’ radar after recent trading left the stock around $117.02, with performance mixed between the past month and the past three months. Here is what current figures reveal. See our latest analysis for Dorman Products. Recent trading has pushed the 1 day share price return to 3.71% and the 1 month share price return to 4.88%. However, the year to date share price return is still down 5.71% and the 1 year total shareholder return has declined 7.44%, while...

VEON (NasdaqGS:VEON) has just delivered a busy stretch of news, with first quarter 2026 results, a higher revenue growth outlook for the year, and fresh balance sheet moves reshaping its capital structure. See our latest analysis for VEON. Despite the earnings update, higher revenue growth guidance and fresh bond issuance, the share price is around $55.11, with short term performance mixed but a very large 3 year total shareholder return that points to strong long term momentum. If VEON's mix...

In its second-quarter 2026 results, Spectrum Brands Holdings reported higher sales of US$708.9 million and net income of US$22.1 million compared with the prior year, alongside sharply improved earnings per share from continuing operations. Management also highlighted a healthy balance sheet and reiterated plans to pursue disciplined acquisitions in its Pet and Home & Garden segments, positioning the company as a potential consolidator in those categories. We’ll now examine how Spectrum...

Earlier in May 2026, Remitly Global, Inc. expanded its Remitly Business offering with new Bulk Payments and Send by Link features for US small and medium-sized businesses, alongside continued rollouts in Canada and the UK and new regulatory approvals in Canada. These additions build on strong early traction for Remitly Business, which is already serving more than 20,000 companies and leveraging the same compliance and disbursement infrastructure used by 9.6 million quarterly active...

Baldwin Insurance Group (BWIN) is on investors’ radar after a rebrand from BRP Group in May 2024. The company’s independent insurance distribution model and its mixed recent share performance over the past month and the past 3 months have drawn particular attention. See our latest analysis for Baldwin Insurance Group. At a share price of $20.12, Baldwin Insurance Group’s 30 day share price return is down 22.08%, while its 90 day share price return is up 21.72%. However, the 1 year total...

Rocket Lab (NasdaqGS:RKLB) has completed its acquisition of Mynaric AG, a provider of laser optical communications terminals. The company has also been selected, alongside RTX (Raytheon), to support the Golden Dome for America defense initiative with launch and satellite services. For investors tracking NasdaqGS:RKLB, these moves add new dimensions to a business many still associate mainly with small launch vehicles and satellite buses. By bringing in Mynaric AG's laser communications...

If you are wondering whether Somnigroup International at US$65.69 still offers value, it helps to break the story down into recent returns, news flow, and what the numbers say about price versus fundamentals. The stock has been volatile, with a 2.7% gain over the last week but a decline of 22.3% over the past month, while the 1 year return sits at 2.5% and the 3 and 5 year returns are 80.9% and 87.2% respectively. Recent coverage has focused on how Somnigroup International fits within the...

Berkshire Hathaway’s complete exit from Domino's Pizza (DPZ) after soft first quarter results and lowered 2026 guidance put the stock under fresh scrutiny, even as the company approved a US$1b buyback and new store openings. See our latest analysis for Domino's Pizza. The recent sell off looks tied to softer Q1 results and Berkshire’s high profile exit, with the 1 year total shareholder return down 33.13% and year to date share price return down 25.70%. However, the last week’s share price...

Berkshire Hathaway exited its long-held stake in Mastercard (NYSE:MA) in the first quarter of 2026. The sale removes Warren Buffett’s indirect exposure to Mastercard and coincides with Greg Abel taking over as Berkshire’s CEO. This move reflects a change in Berkshire’s capital allocation and may influence how some investors view Mastercard’s long-term story. Mastercard operates a global payments network, connecting consumers, merchants and financial institutions across both physical and...

Taysha Gene Therapies recently advanced its lead gene therapy candidate TSHA-102 for Rett syndrome into pivotal development, supported by encouraging early clinical data and FDA Breakthrough Therapy Designation. This combination of regulatory recognition and progress in a condition with significant unmet need could materially influence how investors view Taysha’s long-term opportunity set. We’ll now examine how FDA Breakthrough Therapy Designation for TSHA-102 shapes Taysha Gene Therapies’...

Earlier in May 2026, Donaldson Company extended its more than 30-year record of dividend growth by announcing another increase, supported by solid cash flow and a continued focus on shareholder returns. This dividend hike comes despite insiders selling about US$3.5 million of stock over the past three months, a contrast that investors are watching closely. We’ll now examine how Donaldson’s fresh dividend increase and ongoing cash return stance may influence its broader investment...

At its May 2026 Annual Meeting, LKQ Corporation’s stockholders approved amendments to the company’s charter and bylaws granting holders of at least a combined 25% of common stock the right to request a special stockholder meeting, with these changes becoming effective upon filing in Delaware on May 8, 2026. These governance changes arrive as LKQ faces multiple class action securities lawsuits alleging misleading disclosures around its FinishMaster acquisition and related operational impacts,...

At its Annual General Meeting on May 15, 2026, BioNTech SE shareholders approved expanding the Supervisory Board from six to eight members, electing Prof. Iris Löw-Friedrich and Dr. Susanne Schaffert, both bringing extensive experience in clinical development, oncology, commercialization, and international healthcare markets. The addition of these two industry veterans strengthens BioNTech’s governance bench at a time when clinical execution and oncology-focused commercialization...

Dave (DAVE) is back in focus after analysts raised full-year earnings estimates, with the stock continuing to outperform its Business Services peers and drawing attention to its recent share price and fundamentals. See our latest analysis for Dave. With the share price at $243.8, Dave’s recent 1 day gain of 1.96% and 7 day share price return of 1.55% sit alongside a 90 day share price return of 36.78% and a very large 3 year total shareholder return. However, the 30 day share price return is...

Whether Eagle Materials at around US$200.25 is offering value or asking you to overpay is the core question this article will help you think through. The stock has been relatively quiet in the very short term, edging up 0.4% over the last week. It is down 2.8% over the past month, 5.3% year to date and 6.3% over the last year, while still showing gains of 23.2% over three years and 41.8% over five years. Recent attention on Eagle Materials has centered on how its share price path compares...

Ternium S.A. previously approved at its May 12, 2026 AGM an annual dividend of US$2.20 per ADS (US$0.22 per share), including a US$0.90 per ADS interim payment, with a remaining net dividend of US$1.30 per ADS payable on May 15, 2026 to shareholders of record on May 14, 2026. This dividend decision, including the balance between interim and final payouts, offers investors a window into how management is currently prioritizing cash returns versus reinvestment. We will now examine how this...

In recent analysis of Trinity Industries, investors learned that the company’s railcar backlog has fallen by an average 25.8% over the past two years, while its gross margins trail key competitors in North America. This combination of shrinking orders and thinner margins raises questions about Trinity’s ability to fund growth initiatives and maintain its competitive position in the railcar market. We’ll now examine how the weaker order backlog reshapes Trinity Industries’ existing investment...